Herpes patients at higher risk of Psoriasis, states cohort study Aditi5 Dec 2022 8:00 PM ISTTaiwan: A recent study published in the Australasian Journal of Dermatology has demonstrated an increased risk of Psoriasis in patients diagnosed with...
Patients undergoing ixekizumab therapy for moderate-to-severe psoriasis shows strong adherence Jacinthlyn Sylvia4 Dec 2022 8:00 PM ISTBiologic-naive patients with moderate-to-severe psoriasis (PsO) who were treated with ixekizumab demonstrated greater adherence and continued the...
Patent infringement: Johnson and Johnson sues Amgen over plan to sell drug similar to Stelara Ruchika Sharma1 Dec 2022 1:15 PM ISTIf Amgen launches its drug, J&J said it would infringe J&J's patent on the drug's active ingredient and on its use for treating ulcerative colitis.
Oral probiotics and topical hydrocortisone may reduce severity of Psoriasis Jacinthlyn Sylvia27 Nov 2022 8:00 PM ISTPsoriasis area severity index (PASI), Dermatology life quality index (DLQI), and visual analogue scale (VAS) was improved in psoriasis patients who...
Psoriasis does not increase MI risk among patients with end stage renal disease Jacinthlyn Sylvia8 Nov 2022 8:00 PM ISTA new study published in The American Journal of the Medical Sciences shows that psoriasis was not linked to an elevated risk of myocardial infarction...
Side effects of Steroid Creams- Ft. Dr Bhawuk Dhir, MD Dermatology, RML Hospital, Delhi Dr Bhawuk Dhir31 Oct 2022 4:14 PM ISTIndia's age-old obsession with fair skin is well known, with a large number of skin-bleaching creams available in the market every day, in addition to...
Psoriasis not independent risk factor for MI in people with significant kidney disease Dr. Kamal Kant Kohli19 Oct 2022 8:00 PM ISTStudies in the past have suggested that psoriasis is an independent risk factor for heart attack in the general population.Researchers at Medical...
Biocon Biologics collaborates with Yoshindo to commercialize bUstekinumab, bDenosumab in Japan Ruchika Sharma17 Oct 2022 2:30 PM ISTDenosumab, a biosimilar referencing Prolia, is a monoclonal antibody for the treatment of osteoporosis.
FDA approves new oral treatment Sotyktu for psoriasis Dr. Kamal Kant Kohli13 Sept 2022 10:00 AM ISTThe US Food and drug administration has approved a new oral treatment Sotyktu for plaque psoriasis. In clinical trials, Sotyktu was more effective...
FDA approves spesolimab for treatment of generalized pustular psoriasis flares in adults Dr. Kamal Kant Kohli4 Sept 2022 8:00 PM ISTThe Food and drug administration has approved spesolimab for the treatment of generalized pustular psoriasis flares among adults, according to a Press...
Topical treatment with steroids and vitamin D analogue foam effective in long-term management of psoriasis Jacinthlyn Sylvia19 Aug 2022 8:24 PM ISTFrance: In a new study conducted by Marjorie Heim and team it was found that in psoriasis patients combined topical treatment with...
Childhood-onset psoriasis tied to smoking risk but not alcohol consumption: Study Medha Baranwal9 Aug 2022 8:15 PM ISTFrance: Childhood-onset psoriasis is associated with a higher likelihood of smoking but not socioeconomic status or alcohol consumption, a recent...
